A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations

Neal Van Hoeven, Rhea N. Coler, David E. Clements et al.|PLoS ONE|2016

Cited by 33